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Abstract As our group has shown, the NO-synthase inhibitor 
L-NNA decreased 2-3 times heat shock-induced synthesis of the 
heat shock protein HSP70 (FEBS Lett. 370 (1995) 159-162). It 
was suggested that NO is involved in such induction. In the 
present study, it was found that (1) injection of the NO donor 
dinitrosyl iron complex (DNIC) into rats results in accumulation 
of HSP70 in the heart; (2) heat shock is accompanied by 
increased generation of NO (EPR assay) and HSP70 accumula- 
tion in cultured cells; (3) DNIC induces HSP70 accumulation in 
cultured cells not exposed to heat shock. 
Taken together the data suggest hat NO may contribute to 
the activation of HSP70 synthesis. The goal of the present 
study was to verify this hypothesis. We studied: (1) the effect 
of NO donor injection into rats on HSP70 accumulation in 
the heart; (2) the effect of HS on NO production in cultured 
cells, and (3) the effect of the NO donor on HSP70 accumula- 
tion in cultured cells. 
2. Materials and methods 
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1. Introduction 
It has been shown that heat shock protein (HSP70) syn- 
thesis can be increased by quite different factors, i.e. heat 
shock (HS), acute myocardial ischemia, acute hypoxia, cool- 
ing, etc. [1,2]. HSP70 plays an important role in the restriction 
of stress damage [3] and in enhancing the resistance of the 
heart to ischemia and reperfusion after heat shock [4,5], is- 
chemic preconditioning [6], and adaptation to stress [7]. At the 
same time, the question of what cell mechanisms are involved 
in the activation of HSP70 synthesis remains open in many 
respects. When analyzing this problem, the experimental fact 
has drawn our attention that the same agents can activate 
both HSP70 and nitric oxide (NO) synthesis. For instance, 
lipopolysaccharides, classic inducers of NO synthesis [8], 
also activate HSP70 synthesis [9]. On the other hand, HS, 
which is a conventional factor inducing HSP synthesis 
[1,2,10], is attended by an increase in nitrosyl heme content 
in blood [11]. Our own experiments have demonstrated that 
adaptation of the organism to stress both activates HSP70 
synthesis [7] and potentiates NO generation in the same or- 
gans [12]. We have recently shown that HS-induced tissue 
synthesis of HSP70 is preceded by a transient increase in 
NO production in the same tissue. Furthermore the NO- 
synthase inhibitor NW-nitro-L-arginine (L-NNA) completely 
abolished the HS-induced NO generation and decreased 2-3 
times the HS-induced HSP70 synthesis [13]. 
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2.1. DNIC synthesis 
Dinitrosyl iron complex (DNIC 1:2) with glutathione [(GSH)2-Fe +- 
(NO+)212 was used as the NO donor [14~16]. This complex was 
synthesized in phosphate buffered saline (PBS) according to the meth- 
od described in [14]. It exists in two forms: DNIC 1:2 and DNIC 
1:20. DNIC 1:2 is a dimeric diamagnetic complex synthesized by the 
treatment with NO of a Fe2+-thiol (1:2) solution. DNIC 1:20 is a 
monomeric paramagnetic complex (GSH)2-Fe+-(NO+)2 synthesized 
by the treatment with NO of a Fe2+-thiol (1:20) solution. DNIC 
1:20 is characterized by an EPR signal at g! = 2.041 and g!! = 2.014. 
Parameters of the EPR signal are independent of the nature of the 
thiol ligand (glutathione, cysteine or thiol groups of proteins). DNIC 
1:2 turns into DNIC 1:20 on the addition of thiol to the medium in a 
concentration 20 or more times exceeding that of iron [14]. 
2.2. Animal experiments 
Experiments were carried out on male Wistar rats weighing 250-300 
g. The study was conducted in conformity with the policies and pro- 
cedures detailed in the 'Guide for the Care and Use of Laboratory 
Animals'. 
2.2.1. DNIC treatment. DNIC 1:2 was used as the NO donor [14]. 
It was injected into the caudal vein in the dose of 0.3 mmol/kg body 
weight. 30 and 90 min after the DNIC injection, blood samples (0.2 
ml) were taken from the subclavian vein for measurement of DNIC 
content in blood. Animals were decapitated 24 h following the DNIC 
injection and taken for determination of DNIC content in the blood 
and heart and of HSP70 accumulation i the heart. 
2.2.2. Measurement of DNIC content in the blood and heart. After 
injection, diamagnetic ('EPR-silent') DNIC 1:2 quantitatively trans- 
formed into paramagnetic DNIC 1:20 (see Section 3.1). This allowed 
us to use the EPR assay for determination f the DNIC content by a 
characteristic EPR signal according to a method described elsewhere 
[14]. Samples of blood and tissue were placed in glass ampoules and 
frozen in liquid nitrogen. EPR spectra were recorded on the EPR 
radiospectrometer Radiopan (Poland) in the X-diapason at 77 K, 
amplitude of hf modulation 0.2 mT, and microwave power 5 mW. 
2.2.3. Measurement of blood pressure. Since DNIC releasing NO 
is a potent vasodilator [14], we used blood pressure (BP) as a physio- 
logical indicator of the NO release from DNIC. BP was measured by 
an indirect bloodless method on the tail artery using Physiograph 
DMP-4F (Narco Bio-Systems, USA). 
2.2.4. Electrophoresis and immunoblotting. Reagents and instru- 
ments from Bio-Rad (USA) were used. The heart tissue was ground 
and placed in a hypotonic buffer (10 mM Tris, 10 mM KC1, pH 7.4) 
for 10 min at 4°C. Then the tissue was homogenized in the same 
solution at a buffer:tissue ratio of 5:1 (w/w). The homogenate ob- 
tained was filtered through eight gauze layers and centrifuged at 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PII S00 1 4 -5793(96)0069 1-6 
22 
12 000 X g and 4°C for 10 min. The supematant containing proteins 
was taken for electrophoresis and blotting. Electrophoresis was per- 
formed according to Laemmli [17] in 12% PAAG. They were trans- 
ferred from PAAG to a nitrocellulose membrane according to Towbin 
[18]. Then blots were successively incubated in the presence of mono- 
clonal antibodies (C92) against HSP70 (C92 was a gift from Dr. W.J. 
Welch, San Francisco, CA, USA) at a dilution of 1:500 for 1 h. The 
resulting immune complexes were reacted with horseradish peroxi- 
dase-conjugated anti-mouse Ig (Amersham, UK) and incubated for 
1 h. Finally labeled antigen bands were detected by diaminobenzidine 
staining. For more precise identification of the proteins induced by 
DNIC, they were compared with HSP70 fractions induced by heat 
shock. Heat shock was produced by heating conscious animals in a 
thermostat to a core temperature of 41.5 _+ 0.5°C. After that the heat- 
ing was continued for an additional 15 min. The total duration of 
heating did not exceed 30 min. 
2.3. Cell culture experiments 
Experiments were carried out using a human hepatoblastoma cell 
line, Hep G2. Hep G2 cells were grown on 35 mm plastic dishes. The 
cells were cultured in Eagle's modified minimum essential medium 
(EMEM) supplemented with 1% nonessential mino acids, 2 mM L- 
glutamine, 100 U/ml penicillin, and 100 pg/ml streptomycin, contain- 
ing 10% fetal bovine serum (FBS) and incubated in temperature-con- 
trolled, humidified incubators (5% CO2). 
2.3.1. Heat shock. The cells at near confluence (1.0x106 cells/ 
dish) were exposed to HS by the addition of fresh medium prewarmed 
to 42°C and subsequent incubation at this temperature. After 2 h the 
culture medium was removed, the cells were washed twice with 
EMEM and incubated for 1 or 24 h at 37°C. At the end of incubation 
cells were washed with 1 mM cold PBS, and prepared for the EPR 
assay and Western blotting. 
2.3.2. DNIC treatment. The DNIC solution was added to the 
culture medium at a final concentration of 20 or 100 ~tM. The cells 
were incubated with DNIC. After 15 min, 4 or 24 h the cells and 
medium were EPR-assayed. After 4, 8, 16 or 24 h the cells were 
assayed by Western blot. 
2.3.3. EPR assay. The cells were sedimented by centrifugation at
10000xg for 10 min at 4°C and the pellet was diluted with 0.3 ml of 
the supernatant. The suspension obtained or the medium was placed 
in glass ampoules and frozen in liquid nitrogen. The EPR assay was 
carried out as described above (see Section 2.2.2). 
2.3.4. Electrophoresis and immunoblotting. The cells were washed 
three times with PBS. Cell pellets were suspended at the concentration 
of 2 x 107 ml in 100 ~tl ysis buffer containing 1.0% Nonidet P-40, 150 
mM NaC1, 10 mM EDTA, 100 mM Tris-HC1 at pH 8.0 for 30 min at 
4°C. The insoluble debris was removed by centrifugation at 18 000 x g 
for 10 min at 4°C. Subsequent electrophoresis and immunoblotting 
were performed as described above (see Section 2.2.4). 
2.4. Stat&tical analys& 
Results were statistically treated with Student's t-test and are pre- 
sented as means + S.E.M. 
3. Results and discussion 
3.1. Injection of  D INC 1 .'2 results in appearance of  DNIC  1 .'20 
in blood 
Thirty minutes after the DNIC  1:2 (0.3 ~tmol/kg) injection, 
paramagnetic DNIC  1:20 appeared in blood in a concentra- 
tion of 20 ~tM. This corresponds to 50% of the DNIC  1:2 
injected. After 90 rain and 24 h, DNIC  1:20 was not detected 
in the blood. In the heart DNIC  1:20 was undetectable. 
The appearance of DNIC  in the blood was accompanied by 
a transient decrease in BP from 110 + 3 to 87 + 9 (P< 0.05). 
One hour after DNIC  injection, the BP returned to the initial 
level, which corresponded to the disappearance of DNIC  from 
the blood. 
3.2. DNIC  induces HSP70 accumulation in the rat heart 
It is seen from Fig. 1A that DNIC  (0.3 ktmol/kg body 
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Fig. 1. The effect of DNIC 1:2 on HSP70 accumulation i the heart 
(A) and in Hep G2 cells (B). (A) C: control. DNIC: 0.3 txmol/kg. 
(B) C: control. Lanes 1, 2, 3, 4: 4, 8, 16 and 24 h after DNIC (100 
~tM) addition. Lane 5:24 h after DNIC (20 IxM) addition. 
weight) induced accumulation of HSP70 in the myocardium 
24 h after the injection. This result demonstrates for the first 
time that an NO donor causes accumulation of HSP70. How- 
ever it remains unclear whether this effect was due to a direct 
intracellular action of NO or was mediated by an NO-induced 
change in neuro-humoral regulation. This is why subsequent 
experiments were performed on cultured cells. 
3.3. HS  increases NO generation in cell culture 
Heating of cultured cells for 2 h at 42°C resulted in the 
appearance of endogenous DNIC  1:20 in a concentration of 
2 nmol/106 cells 1 h following HS (Fig. 2). Therefore HS 
potentiated the generation of NO and then the latter formed 
DNIC  with endogenous iron and thiol-containing ligands. 
3.4. DNIC  induces synthesis of  HSP70 in cell culture 
Incubation of hepatocytes with DNIC  1:2 in the concentra- 
tion of 100 ktM resulted in the appearance of DNIC  1:20 
derived from DNIC 1:2 in the cells. From the intensity of 
the EPR signal (peak at g! = 2.041), the intracellular concen- 
tration of DNIC  1:20 was calculated as 5 nmol/106 cells after 
15 min of incubation (Fig. 2). Detection of the EPR signal 
from DNIC 1:20 in cells after contact of the cells with exo- 
genous DNIC  1:2 ensures that this NO donor has really en- 
tered the cell. The major part of DNIC  1:2 remained in the 
extracellular medium. To evaluate the size of this portion, the 
medium was supplemented with 5 mM glutathione. This in- 
duces the transformation of diamagnetic DNIC  1:2 into para- 
magnetic DNIC  1:20 and makes it possible to measure xtra- 
cellular DNIC  1:2 using the EPR method. This concentration 
comprised 75 ~tM which was close to the amount of DNIC  
1:2 added. I f  the extraceUular medium was not treated with 
glutathione, no signal of DNIC  was observed. Within 4 h, 
both extra- and intracellular DNIC  concentrations fell to be- 
low the limit of detection (0.3 nmol per sample). 
Fig. 1B shows that both HS and exogenous DNIC  1:2 
administration induced synthesis of HSP70. The DNIC-in- 
duced HSP70 synthesis was time- and dose-dependent. So, 
for the first time we were able to show that NO itself can 
activate synthesis of HSP70 in cells. It seems reasonable to 
discuss the mechanism of NO-induced activation of HSP70 
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Fig. 2. EPR spectra from hepatocytes and culture medium, a: He- 
patocytes exposed to heat shock, b and c: Hepatocytes 15 min and 
4 h after DNIC addition, respectively, d and e: Culture medium 15 
min and 4 h after DNIC addition, respectively. Recorded at 77 K; 
amplitude of hf modulation 0.2 mT; microwave power 5 mW. Rela- 
tive magnification of the spectrometer in recording spectra a, b, c, 
e: ×10andd:  ×1. 
synthesis. We suggest hat the mechanism ay be as follows. 
It is known that, in basal conditions, the HSP70 transcription 
factor (HSF) is inactive. Stress factors induce trimerization of 
HSF [19]. As a result, the trimeric HSF enters the nucleus and 
activates transcription of hsp70 genes. It is quite possible that 
NO, specifically in its ionized form, nitrazonium ion NO +, 
catalyzes the trimerization process and accelerates the forma- 
tion of disulfide bonds between HSF molecules. DNIC re- 
leases NO in the form of NO + [20]. Based on current notions 
[21], the chemical reaction appears as follows: NO + interacts 
with SH-groups of HSF to form the intermediate S-nitro- 
sothiol. Degradation of the latter with formation of highly 
reactive thiol radicals results in the formation of disulfide 
links between HSF molecules, which leads to trimerization 
and activation of HSF. 
It is commonly accepted that NO is a key molecule in the 
regulation of various physiological processes including the 
immune, nervous and cardiovascular systems [22]. Our results 
supplement this picture: NO can operate as a factor initiating 
the synthesis of the stress protein HSP70. Taking into account 
that HSP70 plays an important role in stress and adaptive 
responses of the organism [1-7], the present results allow us 
to classify the system of NO generation as one that determines 
the resistance of the organism to stress as well as the adaptive 
capacity of the organism. 
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